Business & partnerships

OpenAI acquires Orchestra Bio

OpenAI 20 October 2026 at 02:00

Publication summary. The terms of OpenAI do not allow reproduction of the full article: read the complete text on the original website.

Source summary (English)

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

Read the full article

openai.com

View on OpenAI

Selected by

Amar Syll

Full stack web developer — Symfony, React, DevOps · Lombardy, Italy · available in Grenoble / Lyon

Full stack web developer based in Lombardy (Italy), available in Grenoble and Lyon. I build complete applications, from REST APIs with Symfony / PHP 8 to React interfaces, through deployment on Linux VPS servers that I administer myself: more than 15 applications are now in production. Initially trained in science (Master’s in Physics and Chemistry, UCAD Dakar), then certified as a Web and Mobile Web Developer (RNCP level 5), I designed this platform to follow daily artificial intelligence news directly from the laboratories and publishers behind it. I work in French, Italian and English.

View profile and methodology

X LinkedIn Facebook Email

OpenAI acquires Orchestra Bio

Source summary (English)

Share

OpenAI president Greg Brockman says company could be IPO ready in 2027

Dropbox acquires Tigris Data for $350M to bolster its AI infrastructure

You can post AI music straight to SoundCloud from ElevenLabs

A YC startup is putting $1M behind 5 unsolved materials science problems for AI

Source summary (English)

Share

Related articles

OpenAI president Greg Brockman says company could be IPO ready in 2027

Dropbox acquires Tigris Data for $350M to bolster its AI infrastructure

You can post AI music straight to SoundCloud from ElevenLabs

A YC startup is putting $1M behind 5 unsolved materials science problems for AI